Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
| Report ID | 211795 |
| Drug Identification Number | 02433443 |
| Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
| Common or Proper name | Nystatin Oral Suspension USP |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | NYSTATIN |
| Strength(s) | 100000UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A07AA |
| ATC description | INTESTINALANTIINFECTIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-27 |
| Estimated end date | 2025-08-15 |
| Actual end date | 2025-08-18 |
| Shortage status | Resolved |
| Updated date | 2025-08-18 |
| Company comments | Bottle 500 available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v31 | 2025-08-18 | French | Compare |
| v30 | 2025-08-18 | English | Compare |
| v29 | 2025-08-04 | French | Compare |
| v28 | 2025-08-04 | English | Compare |
| v27 | 2025-08-04 | English | Compare |
| v26 | 2025-07-15 | French | Compare |
| v25 | 2025-07-15 | English | Compare |
| v24 | 2025-06-06 | French | Compare |
| v23 | 2025-06-06 | English | Compare |
| v22 | 2025-01-23 | French | Compare |
| v21 | 2025-01-23 | English | Compare |
| v20 | 2025-01-04 | French | Compare |
| v19 | 2025-01-04 | English | Compare |
| v18 | 2024-12-03 | French | Compare |
| v17 | 2024-12-03 | English | Compare |
| v16 | 2024-10-31 | French | Compare |
| v15 | 2024-10-31 | English | Compare |
| v14 | 2024-10-31 | French | Compare |
| v13 | 2024-10-31 | English | Compare |
| v12 | 2024-09-04 | French | Compare |